Compugen (CGEN) Research & Development (2009 - 2026)
Compugen's (CGEN) quarterly Research & Development came in at $6.9 million in Q1 2026, up 20.16% year-on-year from $5.8 million in Q1 2025, and up 25.15% quarter-over-quarter from $5.5 million in Q4 2025.
Compugen (CGEN) Research & Development (2009 - 2026) Analysis & Trends
Compugen has disclosed Research & Development across 18 years of filings, most recently posting $6.9 million for Q1 2026.
- Research & Development for Q1 2026 came in at $6.9 million, up 20.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $23.9 million (down 1.04% YoY), and the FY2025 annual result was $22.8 million, down 8.27% from the prior year.
- Research & Development came in at $6.9 million for Q1 2026 at Compugen, up from $5.5 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $10.9 million in Q4 2023 to a low of $5.5 million in Q4 2025.
- The 5-year median for Research & Development is $6.8 million (2022), against an average of $7.0 million.
- Across the five-year window, Research & Development jumped 49.15% in 2023 and tumbled 45.91% in 2024, its largest moves.
- Compugen's Research & Development stood at $7.3 million in 2022, then surged by 49.15% to $10.9 million in 2023, then sank by 45.91% to $5.9 million in 2024, then decreased by 6.23% to $5.5 million in 2025, then grew by 25.15% to $6.9 million in 2026.
- The last three Research & Development figures came in at $6.9 million (Q1 2026), $5.5 million (Q4 2025), and $5.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -2.30 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 1.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -58.00 Mn |
| 10 | Compugen | 189.59 Mn | 97.83 Mn | 352,000.00 | 6.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.94 Mn |
| Dec 31, 2025 | 5.54 Mn |
| Sep 30, 2025 | 5.80 Mn |
| Jun 30, 2025 | 5.64 Mn |
| Mar 31, 2025 | 5.77 Mn |
| Dec 31, 2024 | 5.91 Mn |
| Sep 30, 2024 | 6.31 Mn |
| Jun 30, 2024 | 6.18 Mn |
| Mar 31, 2024 | 6.41 Mn |
| Dec 31, 2023 | 10.93 Mn |
| Sep 30, 2023 | 8.34 Mn |
| Jun 30, 2023 | 7.76 Mn |
| Mar 31, 2023 | 7.45 Mn |
| Dec 31, 2022 | 7.33 Mn |
| Sep 30, 2022 | 9.34 Mn |
| Jun 30, 2022 | 6.81 Mn |
| Mar 31, 2022 | 7.17 Mn |
| Dec 31, 2021 | 5.84 Mn |
| Sep 30, 2021 | 8.73 Mn |
| Jun 30, 2021 | 6.80 Mn |